A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus Dose

Trial Profile

A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus Dose

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Feb 2016

At a glance

  • Drugs MDCO 700 (Primary)
  • Indications Pain
  • Focus Adverse reactions; First in man; Pharmacodynamics
  • Sponsors Annovation BioPharma
  • Most Recent Events

    • 17 Feb 2016 According to The Medicines Company media release, the company presented the first clinical results addressing the safety and tolerability of ABP-700 at the ANESTHESIOLOGY 2015 and International Society of Anesthetic Pharmacologists annual meetings.
    • 26 Oct 2015 Results from this trial were presented at the annual meetings of ANESTHESIOLOGY 2015 and The International Society of Anesthetic Pharmacologists, according to The Medicines Company media release.
    • 26 Oct 2015 Results published in The Medicines Company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top